Explore Now
NEW DELHI: Smallcap- and multicap-oriented PMS (portfolio management service) funds, an investment tool of rich investors, outperformed in April and delivered up to 14 per cent returns to clients.
Top guns of the PMS industry also delivered handsome returns for the month. Domestic equity benchmark Sensex fell 1.5 per cent for the month, while Nifty shed 0.4 per cent.
Kotak AMC Pharma Fund finished as the top performer of the month, returning 13.39 per cent, according to data provided by PMSBazaar.
Sun Pharma, Dr Reddy’s Labs, Cipla,
Cadila Healthcare and Aurobindo Pharma were the top five holdings in its portfolio.
Sectoral bets, especially metals, pharma and IT, have been proving to be beneficial for fund managers in the past couple of months, as the Covid-19 pandemic intensified and commodity prices rose.
India
Saurabh-mukherjea
Bharti-airtel
Aurobindo-pharma
Bharat-shah
Varun-malhotra
Sunil-singhania-emerging-opportunities-fund
Pharma-fund
Dr-reddy-labs
Cipla
Master-portfolio-service-vallum-india-discovery
Anvil-wealth-management-long-holding-strategy